about
New β-lactamase inhibitors: a therapeutic renaissance in an MDR world.Antibiotic-resistant gram-negative bacterial infections in patients with cancer.Determining a clinical framework for use of cefepime and β-lactam/β-lactamase inhibitors in the treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae.Correlation of pharmacokinetic/pharmacodynamic-derived predictions of antibiotic efficacy with clinical outcomes in severely ill patients with Pseudomonas aeruginosa pneumonia.[Pharmacokinetics and pharmacodynamics of antibiotics in intensive care].
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Saving lives with optimal antimicrobial chemotherapy.
@en
Saving lives with optimal antimicrobial chemotherapy.
@nl
type
label
Saving lives with optimal antimicrobial chemotherapy.
@en
Saving lives with optimal antimicrobial chemotherapy.
@nl
prefLabel
Saving lives with optimal antimicrobial chemotherapy.
@en
Saving lives with optimal antimicrobial chemotherapy.
@nl
P2860
P356
P1476
Saving lives with optimal antimicrobial chemotherapy.
@en
P2093
G L Drusano
Thomas P Lodise
P2860
P304
P356
10.1093/CID/CIS863
P407
P577
2012-10-16T00:00:00Z